Saccomano Nicholas A - Insider Non-Derivative Transactions at OnKure Therapeutics, Inc. (OKUR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 22, 2025, Saccomano Nicholas A's relationship to OnKure Therapeutics, Inc. (OKUR) is Director,Officer (President and CEO), and currently has 7,419 shares of Class A Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other OKUR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Saccomano Nicholas A - Insider Non-Derivative Transactions of OKUR Class A Common Stock

Saccomano Nicholas A - Insider Non-Derivative Transactions at OKUR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 23, 2025	Sell -- (Class A Common Stock)	87	2.97	7419
Sep 23, 2025	Sell -- (Class A Common Stock)	88	2.62	3506
Jun 24, 2025	Sell -- (Class A Common Stock)	88	2.38	3594
Apr 8, 2025	Sell -- (Class A Common Stock)	516	2.67	3682
Apr 5, 2025	Sell -- (Class A Common Stock)	358	3.33	4198
Oct 5, 2024	Acquisition -- (Class A Common Stock)	4556	0	4556